chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash is a little bit itchy every so often; the rash turns very red, like scars shape like rings; little bumps on their chest; horrible rash on the base of the neck/rash all around the neck; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash is a little bit itchy every so often), RASH ERYTHEMATOUS (the rash turns very red, like scars shape like rings), KERATOSIS PILARIS (little bumps on their chest) and RASH (horrible rash on the base of the neck/rash all around the neck) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced RASH PRURITIC (rash is a little bit itchy every so often), RASH ERYTHEMATOUS (the rash turns very red, like scars shape like rings), KERATOSIS PILARIS (little bumps on their chest) and RASH (horrible rash on the base of the neck/rash all around the neck). At the time of the report, RASH PRURITIC (rash is a little bit itchy every so often), RASH ERYTHEMATOUS (the rash turns very red, like scars shape like rings), KERATOSIS PILARIS (little bumps on their chest) and RASH (horrible rash on the base of the neck/rash all around the neck) had not resolved.            No relevant concomitant medications were reported.  Patient was undergone a Biopsy but results were unavailable.  Patient was treating with steroid injections and steroid cream.
Patient reports experiencing having a clear, oily discharge on the arm of vaccine administration about 2 hours after administration (patient states that vaccine seemed routine, and she did not notice any discharge, moisture, spillage immediately during or after immunization administration); Patient's primary concern is that she received sufficient amount of dose of flu vaccine and does not need to be re-vaccinated. The patient received her flu shot on 8/18/2020, but did not report this to the pharmacy until 10/16/2020. We did not recommend re-vaccination. We also reached out to Sanofi Pasteur for additional information from their medical team to see if they had any recommendations. They also said they could not recommend anything with certainty given the discharge occurred so long after the vaccine was administered, and that the patient took almost 2 months to report this to the pharmacy. The pharmacy has recommended the patient follow up with her physician if she has any additional concerns.
Swelling; Erythema; Fever; Chills; Poly arthralgia.
only one dose received so far; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (only one dose received so far) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (only one dose received so far). At the time of the report, PRODUCT DOSE OMISSION ISSUE (only one dose received so far) outcome was unknown.            No concomitant medication details were provided. No treatment information was mentioned.
tiredness; slight fever; 20 minutes after felt tingle at injection site and front of tongue shortly thereafter then had metallic taste for a couple of days.  Then expected tiredness slight fever 24 hours later not lasting lon; 20 minutes after felt tingle at injection site and front of tongue shortly thereafter then had metallic taste for a couple of days.  Then expected tiredness slight fever 24 hours later not lasting lon; 20 minutes after felt tingle at injection site and front of tongue shortly thereafter then had metallic taste for a couple of days.  Then expected tiredness slight fever 24 hours later not lasting lon; metallic taste; This is a spontaneous report from a contactable consumer. A 61-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0179), via an unspecified route of administration, administered in Arm Left on 07May2021 08:00 as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included magnesium (MAGNESIUM) taken for an unspecified indication, start and stop date were not reported; probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0169), via an unspecified route of administration, administered in Arm Left on 16Apr2021 04:00 pm as dose 1, single for covid-19 immunisation. On 07May2021, the patient experienced 20 minutes after felt tingle at injection site and front of tongue shortly thereafter then had metallic taste for a couple of days, then expected tiredness slight fever 24 hours later not lasting lon, metallic taste. On 08May2021, the patient experienced tiredness, slight fever. No treatment was received for the events. On the unspecified date, the outcome of events was recovered.  Follow-up attempts are completed. No further information is expected.
Information has been received from a registered nurse concerning a 24 year old female who was vaccinated with ATTENUVAX. The nurse mentioned that a patient received the vaccine as a child and became swollen all over. The nurse reported that the patient did not received the vaccine at their office and she did not have any of the physicians information. The patient is recovered. Additional information has been requested.
At 9:15 am on 3/31/21, patient experienced a seizure characterized by unconsciousness and full-body rigidity. He had never previously experienced a seizure. The episode lasted for approximately 5-8 minutes; the patient gradually regained consciousness, but was confused and complained of a headache, eye pain, and nausea for some time afterward. He does not remember the event or what preceded it. He visited the ER that morning. He received an injection of lorazepam and ondansetron. He was held for observation for about 4 hours. He was prescribed a 3 day supply of lorazepam 0.5 mg (taken every 12 hours) upon discharge.
Pt reports to the clinic c/o L arm swelling, hot to touch x 2 days.  Denies pain/touble breathing/signs of anaphylaxis. No hx of reactions with vaccinations in past. NKDA. Tx'd with Benadryl, Ice Packs and Tylenol. Pt verbalized understanding to RTC if s/s worsen.
This is a spontaneous report received from a contactable consumer or other non-HCP. Other case identifier: US-PFIZER INC-202101207303 (same reporter, same vaccine, same AE, different patient). A male patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had nausea and illness (my daughter and son-in-law did), with outcome of unknown. Follow-up attempts completed. No further information expected.
Experienced fever, nausea, vomiting, shakiness, aches, cold, first evening and whole next day, continued nausea and fatigue and achiness off and on, occasional diarrhea for 7 days after. Continued off and on nausea and fatigue, off and on swollen right gland since then. Heart palpitations requiring ER visit two weeks after on 3/11.. still struggling to eat/fatigue and achiness and weakness and heart palpitations coming and going.
Very swollen lymph node in armpit on side of injection.  Appeared ~15 hours after injection, lasted ~36 hours
The next day I awoke with a 100.5 fever, body aches, joint aches, and extreme fatigue.
He did not have any symptoms of COVID-19. His leukemia was acting up so we went to the hospital. They did test and he tested positive for COVID-19. He was in the hospital for 5 days and I don't know if they gave him any medication for COVID-19.  They did a bone marrow biopsy and found out his leukemia was getting worst. He developed a bacteria infection and past away.
Tetanus shot 10-13-06, swelling, redness, severe pain for 2 weeks after. Applied hot and cold compresses and took Ibuprofen. Redness and swelling gave but pain still persists. There is also a loss of strength in my shoulder and arm. I saw MD on 12-15-06. He didn't offer any remedies.
Tightness in left thigh (from first day through 3-4 days following), chest tightness (from first day through 4 days later with gradual decrease in severity), insomnia first day, back and shoulder pain for the first week.
Received appointment 25 days later; This spontaneous case was reported by a consumer and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Received appointment 25 days later) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Received appointment 25 days later). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Received appointment 25 days later) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sunday Morning (2:00 AM) 01/24/2021 woke up with severe chills (body hot), breathing hard.  Lasted about 45 minutes.  took Advil and used the CPAC to calm my breathing down.  Then slept until 9:00 am.  But after I woke, I felt tired the rest of the day.  I am doing fine now.  I am not sure if this was a side effect of the covid vaccine or not. But I thought I let you know.
Patient is (still as of 11/9/15) having severe pain in her left side.  This pain radiates from her neck to her arm.  Pain relievers do not help. Ice is the only thing that reduces the pain.  Seems to be a muscle problem.
15 year old mistakenly injected with vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old mistakenly injected with vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stomach discomfort.   On 27-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old mistakenly injected with vaccine). On 27-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old mistakenly injected with vaccine) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant products were reported. No treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Sep-2021: The recent follow-up document contains Pfizer vaccine.
Received HPV # 3 on 7/15/2009.  This vaccine expired on 6/29/09.  Parents contacted.  Will receive on additional HPV vaccine in 4 hrs to insure efficacy.
No adverse effects; a patient received a dose of MMR II via the intramuscular route; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 24-JUL-2019, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) intramuscularly (incorrect route of product administration), lot # R000556, expiration date 08-JAN-2020 (strength and dose were not reported) for prophylaxis. There was no adverse event reported.
Patient given expired vaccine on 2/8/21 vaccine expired on 1/26/21. Patient reports no adverse event or outcome.
below freezing temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 12-month-old male patient who received HAV (Havrix) (batch number yl532, expiry date 9th September 2022) for prophylaxis.   On 16th July 2021, the patient received Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The physician reported that, the patient was administrated with Havrix after a below freezing temperature excursion, which led to incorrect storage of drug. No adverse event was reported . The reporter consented to follow up. This case is linked with one of 28 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021164791:same reporter US-GLAXOSMITHKLINE-US2021164781:same reporter US-GLAXOSMITHKLINE-US2021164787:same reporter US-GLAXOSMITHKLINE-US2021164783:same reporter US-GLAXOSMITHKLINE-US2021164777:same reporter US-GLAXOSMITHKLINE-US2021164779:same reporter US-GLAXOSMITHKLINE-US2021164775:same reporter US-GLAXOSMITHKLINE-US2021164771:same reporter US-GLAXOSMITHKLINE-US2021164800:same reporter US-GLAXOSMITHKLINE-US2021164769:same reporter US-GLAXOSMITHKLINE-US2021164801:same reporter US-GLAXOSMITHKLINE-US2021164802:same reporter US-GLAXOSMITHKLINE-US2021164784:same reporter US-GLAXOSMITHKLINE-US2021164788:same reporter US-GLAXOSMITHKLINE-US2021164786:same reporter US-GLAXOSMITHKLINE-US2021164789:same reporter US-GLAXOSMITHKLINE-US2021164793:same reporter US-GLAXOSMITHKLINE-US2021164794:same reporter US-GLAXOSMITHKLINE-US2021164795:same reporter US-GLAXOSMITHKLINE-US2021164797:same reporter US-GLAXOSMITHKLINE-US2021164798:same reporter US-GLAXOSMITHKLINE-US2021164799:same reporter US-GLAXOSMITHKLINE-US2021164803:same reporter US-GLAXOSMITHKLINE-US2021164804:same reporter US-GLAXOSMITHKLINE-US2021164805:same reporter US-GLAXOSMITHKLINE-US2021164806:same reporter US-GLAXOSMITHKLINE-US2021164808:same reporter
Fever. Chills. Headache. Tired. Body ache Mainly 6 hours then ok
Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  Tingling to tongue, phlegm to back of throat, tingling inside of mouth.   Assessment : Time of assessment 1205  Alert and oriented. Patient reported after 25 minutes of a 30 minute observation feeling tingling to the inside of her mouth, the tip of her tongue tingling and phlegm to the back of the throat. She denies difficulty swallowing (drinking water), no rashes, no swelling of tongue noted.    Actions taken: Vaers form completed, medications given, observed additional 30 minutes.   There were no vitals filed for this visit.   Medications administered: 1212-Benadryl 12.5 mg elixir by RN; 1215- Pepcid 20 mg po by RN as approved by RN (medication available not scored, so the whole 20 mg tablet given). After 5 minutes per protocol to give additional 12.5 mg Benadryl, patient refused 2nd dose and says she's starting to feel better.   Disposition: After additional 30 minutes observation, patient reports no tingling to tip of tongue and inside of mouth has no tingling. She says the phlegm is still there, but not as much. She is discharged to go home and advised to follow up with her PCP about the symptoms due to she reported after 1st dose when she was going home, she had the same sensation of tingling to the mouth/tongue. I advised to call 911 if symptoms return, she verbalized understanding. Advised to buy some Benadryl liquid to take if needed as instructed by PCP.
body reactions; This case was reported by a consumer and described the occurrence of adverse reaction in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was not recovered/not resolved.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The age at vaccination was not reported. It was reported that the patient experienced body reaction after the vaccination. The patient was still experiencing the after effects ever since, it was worse every day. The patient actually feeling worse now even though it's been a few days. The reporter asked how long it should take. The reporter stated that side effects should have lasted 2 to 3 days. The patient's wife experiencing sore throat, difficult to swallow, conjusted sinuses and headache, but she had never received Shingrix shots. The pharmacist stated that Shingrix was not a live vaccine, it could not cause shingles or sore throat. The reporter asked whether the patient could develop virus that could spread to me. The pharmacist stated the patient could develop a virus but that would be unrelated to Shingrix. In the clinical trials, the most common adverse reactions were pain, redness, and swelling at the injection site. The most common general adverse events were myalgia, fatigue, headache, shivering, fever, and gastrointestinal symptoms. The reporter asked whether 5 day reaction was uncommon.
INJECTION SITE PAIN; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-MAR-2021 23:21 for prophylactic vaccination. The batch number was not reporting and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site pain. This report was non-serious. This case, from the same reporter is linked to 20210322154.
Pt. felt dizziness, fingers tingling, became pale, elevated his feet, all symptoms resolved within 45 minutes.
Body aches, chills, nausea, headaches, hot flashes, dizziness
Vomiting; Disorientation; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 17Mar2021 (Lot number: ER2613) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VOMITING (non-serious) with onset 17Mar2021, outcome "recovered" (17Mar2021), described as "Vomiting"; DISORIENTATION (non-serious) with onset 17Mar2021, outcome "recovered" (17Mar2021), described as "Disorientation". Additional information: The vomiting started in the evening and it resolved about 4 hours after he got the vaccine. The patient noticed the disorientation almost immediately and said that it was like 4 hours of just disorientation. AEs did not require a visit to the emergency room or physician office. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
ED for evaluation. He tested positive for COVID-19 during ED evaluation.  He admits to an occasional cough, admits to shortness of breath with ambulation. Denies chest pain.
3/14/03 Friday night after IPV injection site only red spot. 3/15/03 Sat a.m. left arm at site of IPV red, very swollen area 3" x 3.5" approx, arm feverish. Mom gave Benadryl 2x/day and Ibuprofen every? 6 hrs. 3/19/03 Arm still itching, slightly swollen, site not feverish, red. Mom gave Benadryl and Ibuprofen. 3/11/03 8:30 p.m. mom states child used her left arm throughout ??
Patient complains of dizziness, headache, and nausea 5 minutes after receiving vaccine. Denied difficulty with breathing, blurry vision or weakness.  BP 106/62, HR 72, O2 Sat 97%. Symptoms resolved with rest.
I was symptom free when I went to bed four hours after vaccination.  In the middle of that first night (03/02/21), I awoke with an overall body ache, which persisted through the next day.  In the morning of the next day (03/03/21), I awoke with soreness at the vaccination site, tightness in my chest, and a swollen, red left ankle.  The overall achiness and sore arm were understandable, but the chest tightness made we wonder if inflammation in the region persisted from my cardiac ablation in May 2020 and was aggravated by the covid vaccine.  I have a Kardia home-test ECG monitor, and the results of the test continue to be "normal."  As far as the ankle, an MRI in August 2020 determined that I had torn my peroneal brevis tendon.  After six weeks in a walking boot, I began physical therapy and noticed that if I exerted myself too much that I would get swelling and soreness.  Everything in my ankle was healed by October 2020, and I have been hiking / running four times a week since without incident.  I did not injure myself before the vaccination, so it seems to much of a coincidence that inflammation returned to my previously injured ankle just hours after receiving the covid vaccine.
A huge, hot, red swollen patch suddenly appeared at injection area a week after getting the shot - 6 centimeters by 11 centimeters.  It lasted for 3 days. Arms, back & legs itched days 2&3. Had a mild headache the 3rd day.  The red swollen area  was not tender to touch. My arm didn?t hurt to move and it had full range of motion.
Patient presented to the ED and was subsequently hospitalized for cellulitis of left lower leg within 6 weeks of receiving COVID vaccination.
irregular and rapid heartbeat, dizziness. started on metoprolol 25 mg prn symptoms. the symptoms finally resolved approximately around after about 3 months.
redness & swelling from mid-forearm to clavicle of lt side where dose administered in deltoid;bitten by a cat that was not captured;low risk area;no cases of rabies identified in cats in the area;